Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
NCT04715802 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2025-05-14
Summary
Since polyacrylamide hydrogel (PAAG) was used in cosmetic surgery in 1997, about 30 million women have received PAAG injection for breast augmentation. Although the use of PAAG has been prohibited in most countries due to its myriad complications, a large number of symptomatic patients and asymptomatic patients have continued to seek medical advice. The strategy of repairing secondary breast deformities after PAAG removal has increasingly become a concern for both doctors and patients, but there is no standardized algorithm yet. The purpose of the present study was to perform a retrospective study to compare the safety and effectiveness of different reconstruction timing and method after removing the gel.
Conditions
- Breast
- Mammaplasty
- Breast Reconstruction
Interventions
- PROCEDURE
-
Immediate breast reconstruction with implant
Because most fillers are under the mammary gland, it is better to place the prosthesis into the opening under the pectoralis major muscle, which avoids contact between the prosthesis and the residual hydrogel to reduce the chance of infection. If postoperative complications disappear and imaging shows no filler remnants after more than 3-month follow-up, secondary breast augmentation can be planned. For placement of the prosthesis, the plane under the pectoralis major is preferred, which avoids prosthesis contact with the residual hydrogel to thus reduce the chance of infection.
- PROCEDURE
-
delayed breast reconstruction with implant
The first stage included maximal gel removal and purulent tissue debridement, if necessary. Thereafter, patients were invited for a clinical follow-up and discussion about DBR 3 months later. The latter was offered as a second stage in those opting for it.
- PROCEDURE
-
delayed breast reconstruction with autologous fat transplantation
Because fat injection after PAAG removal has a high infection risk, it is recommended to be conducted after 3-6 months of follow-up. The advantage of autologous fat transplantation is its ability to repair a variety of breast shape deformities caused by PAAG removal. Fat injections may need to be repeated several times. The interval between injections should be at least 3 months. Usually, the amount of transplanted fat is 150-200 mL/side. A multilayer and multi-tunnel injection method is commonly used.
Sponsors & Collaborators
-
First Affiliated Hospital of Zhejiang University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-18
- Primary Completion
- 2022-12-31
- Completion
- 2025-12-31
Countries
- China
Study Locations
More Related Trials
-
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
NCT00581217 ·Status: TERMINATED
-
Evaluation of the Benefit of the Use of Autologous Glue Prepared With RegenKit®-Surgery Device in Abdominoplasty
NCT02930447 ·Status: UNKNOWN ·Phase: NA
-
Amniotic Membrane for Donor Site Healing
NCT02947737 ·Status: COMPLETED ·Phase: NA
-
Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)
NCT01853436 ·Status: TERMINATED ·Phase: NA
-
Diced Cartilage in Breast Reconstruction
NCT06504173 ·Status: COMPLETED
-
Comparison of Cyanoacrylate Tissue Adhesive and Suture for Closure of Cardiac Device Pockets
NCT00674128 ·Status: TERMINATED ·Phase: NA
-
Albumin Use in Burn Patients
NCT00609414 ·Status: COMPLETED
-
Fat Grafting in Skin-grafted Deep Burn Scars
NCT03627650 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Postoperative Effect of Expanded Pedicled Deltopectoral Flap to Repair the Facial-Cervical Scars
NCT03735641 ·Status: UNKNOWN
-
Comparison of Length Gain Between Square Flap and Z-plasty in Post Burn Contracture Release
NCT04690543 ·Status: UNKNOWN ·Phase: NA
-
Case Series Comparing Drains to TissuGlu® in a Donor Site DIEP Flap Breast Reconstruction Procedure
NCT03481140 ·Status: COMPLETED
-
Feasibility Study - The Place of Surgical Management by Fatty Autograft in Patients With Healed Pelvic Eschar. Interest in Secondary Prevention.
NCT03669406 ·Status: UNKNOWN ·Phase: NA
-
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
NCT01062191 ·Status: TERMINATED ·Phase: NA
-
The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
NCT01256502 ·Status: COMPLETED ·Phase: NA
-
StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns
NCT04765202 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)
NCT02595047 ·Status: UNKNOWN ·Phase: NA
-
Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction
NCT05028816 ·Status: COMPLETED ·Phase: NA
-
Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury
NCT04149808 ·Status: WITHDRAWN ·Phase: NA
-
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
NCT05945329 ·Status: RECRUITING ·Phase: NA
-
Applying Platelet Rich Plasma (PRP) Gel to Acute Deep Partial Thickness Thermal Injuries
NCT02169362 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Donated Amnion, Fetal Placental Membrane, as Skin Substitute for Burn Patients
NCT00592189 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures
NCT00558246 ·Status: COMPLETED ·Phase: PHASE4
-
Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars
NCT06566300 ·Status: RECRUITING ·Phase: NA
-
Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery
NCT00964470 ·Status: UNKNOWN ·Phase: NA
-
PMS Study of Silver I Alginate Non-Woven Dressing (Hydro-Alginate)
NCT05690685 ·Status: COMPLETED ·Phase: NA